Literature DB >> 7224356

Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage.

B R Line, G W Hunninghake, B A Keogh, A E Jones, G S Johnston, R G Crystal.   

Abstract

Current concepts of the pathogenesis of sarcoidosis suggest that the alveolitis of this disorder is related to increased numbers of mononuclear phagocytes and activated T-lymphocytes within the lung. To determine if 67Ga scanning, a procedure commonly used in the evaluation of inflammation, would be useful in staging the alveolitis of sarcoidosis, we studied 41 patients with this disorder and correlated estimates of pulmonary 67Ga accumulation with clinical, roentgenographic, physiologic, and bronchoalveolar lavage studies in these patients. Although 65% of patients with sarcoidosis showed increased amounts of 67Ga accumulation in the lung compared with control subjects, only weak correlations (r less than +/- 0.42, all comparisons) were found between the degree of gallium uptake and the clinical, roentgenographic, or physiologic data. In contrast, there was a strong correlation of 67Ga uptake and the number of lymphocytes and T-lymphocytes recovered from the lungs of these patients by bronchoalveolar lavage (p less than 0.0001, r greater than or equal to 0.67, both comparisons). This data suggested that gallium uptake reflects the intensity of the T-lymphocytes mediated component of the alveolitis in sarcoidosis. Because 67Ga scans are noninvasive, simple to perform, and widely available, they should prove useful to stage the activity of sarcoidosis and to make decisions regarding therapy directed against the alveolitis of the disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7224356     DOI: 10.1164/arrd.1981.123.4.440

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  25 in total

Review 1.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis.

Authors:  N J Cook; G J Carroll
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

3.  Interstitial lung disease: aggressive clinical management versus diagnostic and therapeutic nihilism.

Authors:  R G Crystal
Journal:  West J Med       Date:  1982-04

4.  Thoracic imaging with gallium-67.

Authors:  H Klech; H Köhn; M Huppmann; W Pohl
Journal:  Eur J Nucl Med       Date:  1987

5.  Semi-quantitative gallium-67 lung scanning as a measure of the intensity of alveolitis in pulmonary sarcoidosis.

Authors:  G J Duffy; K Thirumurthi; M Casey; F Barker; N Brennan; C Odlum; M X Fitzgerald
Journal:  Eur J Nucl Med       Date:  1986

6.  Severe spirometric defects in systemic lupus erythematosus. A possible role for bronchoalveolar lavage and gallium scanning.

Authors:  R Y Lin
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

7.  Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis.

Authors:  Alessandro Antonelli; Piera Fazzi; Poupak Fallahi; Silvia Martina Ferrari; Mariano Grosso; Giuseppe Boni; Ele Ferrannini; Giuliano Mariani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-09       Impact factor: 9.236

8.  Sarcoidosis: a truly protean disease.

Authors:  V Lopez-Majano
Journal:  Eur J Nucl Med       Date:  1984

9.  Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell subset imbalance at sites of disease activity.

Authors:  G A Rossi; O Sacco; E Cosulich; G Damiani; G Corte; A Bargellesi; C Ravazzoni
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

10.  Assessment of progression of asbestosis in the sheep model by bronchoalveolar lavage and pulmonary function tests.

Authors:  R Bégin; M Rola-Pleszczynski; S Massé; D Nadeau; G Drapeau
Journal:  Thorax       Date:  1983-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.